Jrn Pharma And Laboratories Llp Profile
Key Indicators
- Obligation of Contribution ₹ 10.00 Cr
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 58.00 Cr
About Jrn Pharma And Laboratories Llp
Jrn Pharma And Laboratories Llp (JPALL) is 5 Year, 3 Months old Limited Liability Partnership 11 November 2019. Its registered office is in Marigaon, Assam, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2022 (FY 2021-2022). It's Total Obligation of Contribution is Rs 10.00 Cr as per MCA.
Company Details
-
Location
Marigaon, Assam, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAR-0055
-
Incorporation Date
11 Nov 2019
-
Date of Accounts and Solvency Statement
31 Mar 2022
-
ROC Code
Roc-Shillong
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Jrn Pharma And Laboratories Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lucky Jit
|
Designated Partner | 12-Feb-2021 | Current |
|
Jit Srivastava
|
Designated Partner | 11-Nov-2019 | Current |
Financial Performance of Jrn Pharma And Laboratories Llp.
Enhance accessibility to Jrn Pharma And Laboratories Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jrn Pharma And Laboratories Llp?
Unlock access to Jrn Pharma And Laboratories Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Jrn Contracts And Pharmaceutical Private LimitedLucky Jit and Jit Srivastava are mutual person
-
Omex Chemical Private Limited
Jit Srivastava is a mutual person
-
Jrn Industries Limited
Jit Srivastava is a mutual person
-
Jrn Pharma Limited
Jit Srivastava is a mutual person
Charges (Loans)
₹58.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 34.00 Cr
- Bank Of Maharashtra : 24.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2022 | Bank Of India | ₹34.00 Cr | Open |
| 10 Mar 2022 | Bank Of Maharashtra | ₹0.00 | Open |
| 10 Mar 2022 | Bank Of Maharashtra | ₹24.00 Cr | Open |
How Many Employees Work at Jrn Pharma And Laboratories Llp?
Jrn Pharma And Laboratories Llp has a workforce of 38 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jrn Pharma And Laboratories Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jrn Pharma And Laboratories Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.